Publications by authors named "L Bisigniano"
Introduction: The age for kidney transplantation (KT) is no longer a limitation and several studies have shown benefits in the survival of elderly patients. The aim of this study was to examine the relationship of the baseline Charlson comorbidity index (CCI) score to morbidity and mortality after transplantation.
Methods: In this multicentric observational retrospective cohort study, we included patients older than 60 years admitted on the waiting list (WL) for deceased donor KT from January 01, 2006, to December 31, 2016.
Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI.
Hematol Transfus Cell Ther
April 2022
Introduction: Hematopoietic stem cell transplantation is the only curative treatment for many disorders and international data shows a growing trend.
Method: We aimed to evaluate the temporal trends in HSCT transplant rates in Argentina. A time-series analysis was performed for the period 2009 to 2018 using the national database from the National Central Coordinating Institute for Ablations and Implants.
Article Synopsis
- - The Argentine Registry of COVID in chronic dialysis reported data from April 2020 to April 2021, registering 36,918 patients on dialysis, with 10% (3,709) confirmed COVID-19 cases.
- - Of those infected, 45.2% were hospitalized, with 39% requiring ICU care, and 62% of ICU patients needing mechanical ventilation; the overall death rate was 35.24%.
- - Factors linked to higher mortality in dialysis patients included age over 60, diabetes, extended dialysis duration, and the necessity for hospitalization or ICU admission, indicating a critical need for focused care and vaccination strategies in this high-risk group.
The COVID-19 pandemic declared in March 2020, has generated worldwide concern due to its effect on the health of the population and the potential health collapse. The strategy of "flattening the curve" through social distancing made it possible to adapt the resources of the health system to patients with COVID-19, but results in other areas of health could not be predicted. The objective of this work was to analyze the consequences of the pandemic on liver transplantation in general and for hepatocarcinoma (HCC).
View Article and Find Full Text PDF